Leon J Worth

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi request reprint Staphylococcus aureus bloodstream infection in Australian hospitals: findings from a Victorian surveillance system
    Leon J Worth
    Victorian Healthcare Associated Infection Surveillance System Coordinating Centre, Melbourne, Vic, Australia
    Med J Aust 200:282-4. 2014
  2. doi request reprint Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control p
    Leon J Worth
    Victorian Hospital Acquired Infection Surveillance System VICNISS Coordinating Centre, North Melbourne, Victoria, Australia
    Am J Infect Control 37:643-8. 2009
  3. doi request reprint Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia
    Emma S McBryde
    Victorian Infectious Diseases Service, Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Infect Control Hosp Epidemiol 30:1045-9. 2009
  4. doi request reprint Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition
    Leon J Worth
    Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    Infect Control Hosp Epidemiol 29:358-60. 2008
  5. doi request reprint Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices
    Leon J Worth
    Centre for Clinical Research Excellence in Infectious Disease, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, 3052, Australia
    Support Care Cancer 17:811-8. 2009
  6. doi request reprint Bloodstream infections in haematology: risks and new challenges for prevention
    Leon J Worth
    Department of Infectious Diseases, Peter MacCallum Cancer Centre, Victoria, Australia
    Blood Rev 23:113-22. 2009
  7. doi request reprint Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis
    Gabrielle M Haeusler
    Department of Infectious Diseases and Infection Control, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
    Eur J Haematol 91:157-63. 2013
  8. doi request reprint Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients
    Stephen D Guy
    Department of Infectious Diseases, Western Health, Private Bag, Footscray, Victoria, Australia 3011
    Eur J Nucl Med Mol Imaging 39:1348-55. 2012
  9. doi request reprint Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications
    Piers Blombery
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia
    Ann Hematol 90:1167-72. 2011
  10. doi request reprint Is it possible to achieve a target of zero central line associated bloodstream infections?
    Leon J Worth
    Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    Curr Opin Infect Dis 25:650-7. 2012

Detail Information

Publications13

  1. ncbi request reprint Staphylococcus aureus bloodstream infection in Australian hospitals: findings from a Victorian surveillance system
    Leon J Worth
    Victorian Healthcare Associated Infection Surveillance System Coordinating Centre, Melbourne, Vic, Australia
    Med J Aust 200:282-4. 2014
    ..To determine the burden of disease and trend over time for rates of Staphylococcus aureus bloodstream (SAB) infections in Victorian health care services...
  2. doi request reprint Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control p
    Leon J Worth
    Victorian Hospital Acquired Infection Surveillance System VICNISS Coordinating Centre, North Melbourne, Victoria, Australia
    Am J Infect Control 37:643-8. 2009
    ..Effective and comparable surveillance for central venous catheter-related bloodstream infections (CLABSIs) in the intensive care unit requires a reproducible case definition that can be readily applied by infection control professionals...
  3. doi request reprint Validation of statewide surveillance system data on central line-associated bloodstream infection in intensive care units in Australia
    Emma S McBryde
    Victorian Infectious Diseases Service, Centre for Clinical Research Excellence in Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia
    Infect Control Hosp Epidemiol 30:1045-9. 2009
    ....
  4. doi request reprint Surveillance for catheter-associated bloodstream infection in hematology units: quantifying the characteristics of a practical case definition
    Leon J Worth
    Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    Infect Control Hosp Epidemiol 29:358-60. 2008
    ..0% sensitivity and 94.3% specificity. This case definition provides a practical method for effectively excluding CVC-associated bloodstream infection...
  5. doi request reprint Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices
    Leon J Worth
    Centre for Clinical Research Excellence in Infectious Disease, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, 3052, Australia
    Support Care Cancer 17:811-8. 2009
    ..The objectives of this study were to determine the natural history and rate of CVC-related complications and risk factors for CR-BSI and to compare device-specific complications in a hematology population...
  6. doi request reprint Bloodstream infections in haematology: risks and new challenges for prevention
    Leon J Worth
    Department of Infectious Diseases, Peter MacCallum Cancer Centre, Victoria, Australia
    Blood Rev 23:113-22. 2009
    ..To reduce the rate and impact of bloodstream infections multifaceted and customised strategies are required within individual haematology units...
  7. doi request reprint Late-onset Pneumocystis jirovecii pneumonia post-fludarabine, cyclophosphamide and rituximab: implications for prophylaxis
    Gabrielle M Haeusler
    Department of Infectious Diseases and Infection Control, Peter MacCallum Cancer Centre, East Melbourne, Vic, Australia
    Eur J Haematol 91:157-63. 2013
    ..The objective of this study was to review the incidence of PJP during and post-FCR in the era of highly sensitive molecular diagnostics and (18) F-fluorodeoxyglucose (FDG) positron emission tomography (PET)-computerised tomography (CT)...
  8. doi request reprint Use of FDG PET/CT for investigation of febrile neutropenia: evaluation in high-risk cancer patients
    Stephen D Guy
    Department of Infectious Diseases, Western Health, Private Bag, Footscray, Victoria, Australia 3011
    Eur J Nucl Med Mol Imaging 39:1348-55. 2012
    ..The aim of this study was to prospectively evaluate the clinical utility of FDG PET/CT in patients with cancer and severe neutropenia and five or more days of persistent fever despite antibiotic therapy...
  9. doi request reprint Prophylactic intravenous immunoglobulin during autologous haemopoietic stem cell transplantation for multiple myeloma is not associated with reduced infectious complications
    Piers Blombery
    Division of Cancer Medicine, Peter MacCallum Cancer Centre, East Melbourne, Melbourne, Victoria, Australia
    Ann Hematol 90:1167-72. 2011
    ..4 g/kg) to reduce infectious complications in a large cohort of patients with myeloma undergoing ASCT. In the absence of data supporting efficacy in this context, there appears to be no benefit in the routine use of IVIG for this purpose...
  10. doi request reprint Is it possible to achieve a target of zero central line associated bloodstream infections?
    Leon J Worth
    Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
    Curr Opin Infect Dis 25:650-7. 2012
    ..Although a zero target is proposed, the feasibility has not been evaluated. The objective of this review is to identify factors contributing to CLABSI and determine whether current evidence supports attainment of a zero infection rate...
  11. doi request reprint Impact of vancomycin surgical antibiotic prophylaxis on the development of methicillin-sensitive staphylococcus aureus surgical site infections: report from Australian Surveillance Data (VICNISS)
    Ann L Bull
    Victorian Healthcare Associated Surveillance System VICNISS Coordinating Centre, North Melbourne, Australia
    Ann Surg 256:1089-92. 2012
    ..To compare risks for developing surgical site infection (SSI) due to Staphylococcus aureus when vancomycin is used for antibiotic prophylaxis with risks when a β-lactam antibiotic is administered for prophylaxis...
  12. doi request reprint Stenotrophomonas maltophilia: emerging disease patterns and challenges for treatment
    Iain J Abbott
    Department of Infectious Diseases, Peter MacCallum Cancer Centre, East Melbourne, Victoria, Australia
    Expert Rev Anti Infect Ther 9:471-88. 2011
    ..Finally, measures to prevent transmission of S. maltophilia within healthcare facilities are reported, especially in at-risk patient populations...
  13. ncbi request reprint Catheter-related bloodstream infections in hematology: time for standardized surveillance?
    Leon J Worth
    Centre for Clinical Research Excellence in Infectious Disease, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Cancer 109:1215-26. 2007
    ..Only when these issues are addressed can a surveillance strategy reliably assess trends and compare data, leading to improved patient outcomes and a reduction in healthcare expenditure for patients with hematologic malignancy...